Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Feb 15;176(3):687–696. doi: 10.1007/s10549-019-05165-4

Table 1.

Selected demographic variables by case-control status by study

Discovery Validation
Case Control P-value* Case Control P-value*
(N=134) (N=57) (N=224) (N=81)
Age, mean(SD) 51.1(12.0) 51.1(6.7) 0.990 50.6(10.7) 58.4(14.8) <0.001
BMI, mean(SD) 31.1(6.2) 30.4(7.0) 0.499 32.8(7.7) 33.4(8.3) 0.599
BMI category N(%)
 normal(<25) 18(13.43) 17(29.82) 28(12.11) 10(12.35)
 overweight(25–<3 0) 45(33.58) 15(26.32) 63(28.25) 26(32.10)
 obese(30+) 71(52.99) 25(43.86) 0.027 133(59.64) 45(55.56) 0.790
Race
 African Americans 57(42.54) 19(33.33) 93(41.52) 57(70.37)
 Hispanic 77(57.46) 38(66.67) 0.234 131(58.48) 24(29.63) <0.001
Family history of breast cancer
 0 113(84.33) 50(87.72) 195(87.05) 70(86.42)
 1 21(15.67) 7(12.28) 0.544 29(12.95) 11(13.58) 0.885
ER
 positive 100(74.63) 157(70.09)
 negative 34(25.37) 67(29.92)
PR
 positive 77(57.46) 134(59.82)
 negative 57(42.54) 90(40.18)
HER2
 positive 30(22.38) 35(15.63)
 negative 104(77.61) 189(84.37)
Stage
 I 44(32.83) 72(32.14)
 II 44(32.83) 90(40.18)
 III & IV 46(34.33) 62(27.68)
*

Student T test was used to calculate the P value for continuous variables; and Chi square was used to calculate the P value for categorical variables.